Lv5
1320 积分 2026-07-08 加入
Endoplasmic reticulum stress-MMRN1 positive feedback contributes to cisplatin resistance in small cell lung cancer
29天前
已完结
Data from AdCD40L Immunogene Therapy for Bladder Carcinoma—The First Phase I/IIa Trial
1个月前
已关闭
Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T‐cells
1个月前
已完结
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
1个月前
已完结
The next generation of immunotherapies for lung cancers
1个月前
已完结
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer
1个月前
已完结
Targeting the Notch signaling pathway and the Notch ligand, DLL3, in small cell lung cancer
1个月前
已完结
Trained immunity-primed DLL3-targeted CAR macrophages for the eradication of small cell lung cancer
1个月前
已完结
VHH-Based CAR-T Cells Targeting DLL3 Show High Efficacy in Small Cell Lung Cancer Models
1个月前
已完结
Brief Report: Low Delta-Like Ligand 3 Expression and T-Cell Exhaustion Drive Resistance to Tarlatamab Combined With Anti-Programmed Cell Death Protein 1 in SCLC
1个月前
已完结
皖公网安备34019202002308
